Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 2201 - 2208 of 11685 results
Life-Changing Support Services Help Veterans Move Forward
February 28, 2022| Article| Viewpoint
Justices Bolster Copyrights With Decision Curbing Challenges
February 25, 2022| News
ML Strategies Energy & Sustainability Washington Updates - March 2022
February 25, 2022| Blog| Viewpoint
New York To Require Licensure of Pharmacy Benefit Managers
February 25, 2022| Blog| Viewpoint
Plaintiff Can Assert Patent Infringement and Seek Injunctive Relief in Second-Phase BPCIA Litigation Per Illinois District Court Decision
February 24, 2022| Blog| Viewpoint
Entrepreneurs of Color Receive Strategic Guidance
February 22, 2022| Article| Viewpoint
USCIS H-1B Cap Registration Period Set to Open on March 1
February 22, 2022| Alert| Viewpoint
Monthly TCPA Digest — February 2022
February 22, 2022| Article| Viewpoint
News & Press Releases
Mintz Expands Energy & Sustainability Practice with Projects & Infrastructure Member Luis F. Torres
January 27, 2025
Luis F. Torres has joined as a Member of Mintz’s Energy & Sustainability Practice in the firm’s Washington, DC and New York offices. An accomplished project finance lawyer, Luis’s practice focuses on the structuring, development, and financing of energy, transport, telecommunications, and other infrastructure projects in the United States, Latin America, and other jurisdictions around the globe.
Mintz represented Quorum Cyber Security, a platform company of Charlesbank Capital Partners, in its acquisition of Kivu Consulting, Inc., a global cybersecurity firm specializing in Incident Response.
Mintz Represents Granata Bio Corporation in Series A+ Funding Round
January 24, 2025
Mintz represented Granata Bio Corporation (Granata Bio), a biopharma company focused on invigorating the $3.6B global infertility medication market, in its $15M Series A+ funding round.